Skip to content

The effect of Ziziphus jujube fruit on blood sugar control and lipid profiles in people with type 2 diabetes

Effect of Ziziphus jujube fruit on glycemic control and lipid profiles in people with type2 diabetes :A randomized double blinded placebo-controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200418047116N2
Enrollment
120
Registered
2020-11-18
Start date
2020-11-21
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Standard Drugs + Ziziphus jujube fruit powder 20 g two times a day for three months. Intervention 2: Control group: Standard Drugs + placebo (in terms of sachet co

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Being between 30 and 70 years old Having a confirmed diagnosis of type 2 diabetes according to the American Diabetes Association Having type 2 diabetes for less than 10 years Have a glycosylated hemoglobin (A1C) level of less than 10% Have an LDL or TG or T-Chol level above the normal range or HDL below the normal range Having a glucometer to measure fasting blood sugar No history of allergy to ziziphus jujube fruit consumption (according to self-report) Lack of liver problems, kidney failure and cancer No consumption of ziziphus jujube or other herbal medicines during the last 4 weeks before the start of the study No history of addiction Non-pregnancy and lactation for women Lack of experience of acute and severe stress during the last 2 weeks before the start of the study No gastrointestinal symptoms after milk consumption (lactose intolerance) Having informed consent to participate in the research

Exclusion criteria

Exclusion criteria: Existence of addiction Coagulation disorders or the use of anticoagulants Consumption of other herbal medicines that affect the results of the study and its validity

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar (FBS). Timepoint: before intervention and three months after intervention. Method of measurement: laboratory instruments.;Low density lipoprotein (LDL). Timepoint: before intervention and three months after intervention. Method of measurement: laboratory instruments.;Glycosylated hemoglobin (A1C). Timepoint: before intervention and three months after intervention. Method of measurement: laboratory instruments.;High density lipoprotein (HDL). Timepoint: before intervention and three months after intervention. Method of measurement: laboratory instruments.;Total cholesterol (chol-T). Timepoint: before intervention and three months after intervention. Method of measurement: laboratory instruments.;Triglyceride (TG). Timepoint: before intervention and three months after intervention. Method of measurement: laboratory instruments.

Secondary

MeasureTime frame
BMI. Timepoint: before intervention and three months after intervention. Method of measurement: Measurement of weight and height.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegar Shafaei Bajestani

Gonabad University of Medical Sciences

Shafaei.n@gmu.ac.ir+98 51 5723 6833

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026